These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25066104)

  • 1. Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.
    De Jesús VR; Adam BW; Mandel D; Cuthbert CD; Matern D
    Mol Genet Metab; 2014; 113(1-2):67-75. PubMed ID: 25066104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening.
    Varughese B; Madrewar D; Polipalli SK; Kapoor S
    Indian J Clin Biochem; 2022 Jan; 37(1):40-50. PubMed ID: 35125692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1.
    van Vliet K; Dijkstra AM; Bouva MJ; van der Krogt J; Bijsterveld K; van der Sluijs F; de Sain-van der Velden MG; Koop K; Rossi A; Thomas JA; Patera CA; Kiewiet MBG; Waters PJ; Cyr D; ; Boelen A; van Spronsen FJ; Heiner-Fokkema MR
    J Inherit Metab Dis; 2023 Nov; 46(6):1104-1113. PubMed ID: 37545091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening.
    Priestley JRC; Alharbi H; Callahan KP; Guzman H; Payan-Walters I; Smith L; Ficicioglu C; Ganetzky RD; Ahrens-Nicklas RC
    Int J Neonatal Screen; 2020 Jun; 6(2):. PubMed ID: 32832707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone.
    Dijkstra AM; Evers-van Vliet K; Heiner-Fokkema MR; Bodewes FAJA; Bos DK; Zsiros J; van Aerde KJ; Koop K; van Spronsen FJ; Lubout CMA
    Int J Neonatal Screen; 2023 Dec; 9(4):. PubMed ID: 38132825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference values of amino acids, acylcarnitines and succinylacetone by tandem mass spectrometry for use in newborn screening in southwest Colombia.
    Céspedes N; Valencia A; Echeverry CA; Arce-Plata MI; Colón C; Castiñeiras DE; Hurtado PM; Cocho JA; Herrera S; Arévalo-Herrera M
    Colomb Med (Cali); 2017 Sep; 48(3):113-119. PubMed ID: 29213153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of reference intervals for dried blood spot based ms/ms newborn screening programs in Chinese preterm neonates: a nationwide study.
    He F; Xie T; Huang X; Zhang J; Tang T
    BMC Pediatr; 2024 Jul; 24(1):424. PubMed ID: 38956494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatorenal tyrosinemia.
    Kitagawa T
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(5):192-200. PubMed ID: 22687740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository.
    Sontag MK; Miller JI; McKasson S; Sheller R; Edelman S; Yusuf C; Singh S; Sarkar D; Bocchini J; Scott J; Ojodu J; Kellar-Guenther Y
    PLoS One; 2020; 15(4):e0231050. PubMed ID: 32240266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with urinary succinylacetone-negative hereditary tyrosinemia type 1.
    Mori J; Furukawa T; Kodo K; Nakajima H; Yuasa M; Kubota M; Shigematsu Y
    Pediatr Int; 2023; 65(1):e15644. PubMed ID: 37795850
    [No Abstract]   [Full Text] [Related]  

  • 11. Newborn screening for the full set of mucopolysaccharidoses in dried blood spots based on first-tier enzymatic assay followed by second-tier analysis of glycosaminoglycans.
    Herbst ZM; Hong X; Sadilek M; Fuller M; Gelb MH
    Mol Genet Metab; 2023 Nov; 140(3):107698. PubMed ID: 37820575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders From Dried Blood Spots.
    Collins CJ; Yi F; Dayuha R; Whiteaker JR; Ochs HD; Freeman A; Su HC; Paulovich AG; Segundo GRS; Torgerson T; Hahn SH
    Front Immunol; 2020; 11():464. PubMed ID: 32296420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Newborn blood spot screening (NBS) in Germany : Status quo and presentation of a concept for further development].
    Nennstiel U; Odenwald B; Throner V; Blankenstein O; Vieth A; Ratzel R; Coenen M; Brockow I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Nov; 66(11):1195-1204. PubMed ID: 37815611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC's Laboratory Activities to Support Newborn Screening for Spinal Muscular Atrophy.
    Lee FK; Greene C; Mercer K; Taylor J; Yazdanpanah G; Vogt R; Lee R; Cuthbert C; Cordovado S
    Int J Neonatal Screen; 2024 Jul; 10(3):. PubMed ID: 39051407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of newborn screening for six lysosomal diseases in Brazil.
    Kubaski F; Sousa I; Amorim T; Pereira D; Silva C; Chaves V; Brusius-Facchin AC; Netto ABO; Soares J; Vairo F; Poletto E; Trometer J; Souza A; Ranieri E; Polo G; Hong X; Herbst ZM; Burlina A; Gelb MH; Giugliani R
    Mol Genet Metab; 2023; 140(1-2):107654. PubMed ID: 37507255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation.
    Hale K; Kellar-Guenther Y; McKasson S; Singh S; Ojodu J
    Int J Neonatal Screen; 2020 Jun; 6(2):48. PubMed ID: 33073038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing based newborn screening and comparative analysis with MS/MS.
    Shen G; Li W; Zhang Y; Chen L
    BMC Pediatr; 2024 Apr; 24(1):230. PubMed ID: 38561707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Cases of Maleylacetoacetate Isomerase Deficiency with Detection by Newborn Screening and Natural History over 32 Years: Experience from a German Newborn Screening Center.
    Gramer G; Wortmann SB; Fang-Hoffmann J; Kohlmüller D; Okun JG; Prokisch H; Meitinger T; Hoffmann GF
    Int J Neonatal Screen; 2024 Feb; 10(1):. PubMed ID: 38535121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress of newborn screening in China.
    Jiang H; Yang R; Dong A; Wu B; Zhao Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 52(6):673-682. PubMed ID: 38115737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing for newborn screening: are we there yet?
    Friedman E
    Genet Res (Camb); 2015 Sep; 97():e17. PubMed ID: 26392239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.